IFNG and pulmonary fibrosis: Hence, the combination therapy of PHPS1 + IFN-γ or BIBF 1120 + IFN-γ significantly inhibits fibroblast–myofibroblast transformation to mitigate pulmonary fibrosis (Chang et al. 2021).